Highlights
IIA supported (ever)1 patent
About
Cord Blood Collection Device
SituGen is a medical device startup that has developed a comprehensive system for extracting stem-cell-rich umbilical cord blood. The companys patented SG1040 is a disposable, all-inclusive, non-contaminating collection kit designed to increase the quality of cord blood and the number of stem cells extracted. The novel device is needle-free, preventing the bottleneck effect associated with needles. SituGen is an Israel-based company and part of the Rad-Bynet Group of multinational technology companies.
Identity
| Name | Situgen Med |
|---|---|
| Slug | situgen-med |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAkOzcqr4LDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Tel Aviv-Yafo |
| HQ address | Ha-Arad Street 7, Tel Aviv-Yafo, Israel |
Web & social
| Website | https://www.situgen.com |
|---|---|
| https://www.linkedin.com/company/17882433 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesMedical Devices IndustryMedical Products
Business models
B2B
Tags
medical-devicespregnancymedical-technologiesminimally-invasiveblood-testnon-invasivehematology
Funding
| Total raised | — |
|---|---|
| Current stage | Mature |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}